ArticleOncology letters2015

Lapatinib combined with neoadjuvant paclitaxel-trastuzumab-based chemotherapy in patients with human epidermal growth factor receptor 2-positive breast cancer: A meta-analysis of randomized controlled trials.

Jinzhong Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.